-
embryology, cardiac phenotyping, and transcriptomic and proteomic profiling. We seek a PhD or MD/PhD with a first-author publication record, mouse experience, and strong molecular biology skills; background in
-
using proteomics. (3) determine differences between DsbA proteins of two model organisms, E. coli and M. smegmatis (4) Establishing termini restraining for inhibitor-protein crystallography in
-
topics to work on: (1) In vitro assays to determine inhibitor efficacy against redox membrane proteins (2) Cysteine enrichment of DsbA substrates in E. coli and Mycobacteria using proteomics. (3) determine
-
communication skills. Preferred Genome-wide association studies (GWAS) Statistical genetics and polygenic scores Single-cell RNA-seq, proteomics, or other multi-omics analyses Artificial intelligence and machine
-
are currently using include: organoid culture, CRISPR genome editing, CUT&RUN/ChIP, scRNA-seq/scATAC-seq, 3D imaging/expansion microscopy, proteomics, and mathematical modeling. IUSM is committed to being a
-
discovery to identify children at risk for developing kidney disease and to guide personalized treatment strategies. By leveraging advanced technologies in genomics, proteomics, and metabolomics, our goal is
-
/Cas9, single cell RNA-seq, cell culture with live cell imaging, immunohistochemistry with confocal microscopy, Ca2+ imaging, coimmunoprecipitation and proteomics. IUSM is committed to being a welcoming